Literature DB >> 15784556

Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens.

Wanyin Deng1, Yuling Li, Philip R Hardwidge, Elizabeth A Frey, Richard A Pfuetzner, Sansan Lee, Samantha Gruenheid, Natalie C J Strynakda, Jose L Puente, B Brett Finlay.   

Abstract

Human enteropathogenic Escherichia coli (EPEC), enterohemorrhagic E. coli (EHEC), and the mouse pathogen Citrobacter rodentium (CR) belong to the family of attaching and effacing (A/E) bacterial pathogens. They possess the locus of enterocyte effacement (LEE) pathogenicity island, which encodes a type III secretion system. These pathogens secrete a number of proteins into culture media, including type III effector proteins and translocators that are required for the translocation of effectors into host cells. Preliminary evidence indicated that the LEE-encoded SepL and Rorf6/SepD may form a molecular switch that controls the secretion of translocators and effectors in CR. Here, we show that SepL and SepD indeed perform this function in A/E pathogens such as EHEC and EPEC. Their sepL and sepD mutants do not secrete translocators but exhibit enhanced secretion of effectors. We demonstrate that SepL and SepD interact with each other and that both SepL and SepD are localized to the bacterial membranes. Furthermore, we demonstrate that culture media influence the type III secretion profile of EHEC, EPEC, and CR and that low-calcium concentrations inhibit secretion of translocators but promote the secretion of effectors, similar to effects on type III secretion by mutations in sepL and sepD. However, the secretion profile of the sepD and sepL mutants is not affected by these culture conditions. Collectively, our results suggest that SepL and SepD not only are necessary for efficient translocator secretion in A/E pathogens but also control a switch from translocator to effector secretion by sensing certain environmental signals such as low calcium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784556      PMCID: PMC1087438          DOI: 10.1128/IAI.73.4.2135-2146.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  CesAB is an enteropathogenic Escherichia coli chaperone for the type-III translocator proteins EspA and EspB.

Authors:  Elizabeth A Creasey; Devorah Friedberg; Robert K Shaw; Tatiana Umanski; Stuart Knutton; Ilan Rosenshine; Gad Frankel
Journal:  Microbiology       Date:  2003-12       Impact factor: 2.777

2.  SepL, a protein required for enteropathogenic Escherichia coli type III translocation, interacts with secretion component SepD.

Authors:  Colin B O'Connell; Elizabeth A Creasey; Stuart Knutton; Simon Elliott; Lynette J Crowther; Wensheng Luo; M John Albert; James B Kaper; Gad Frankel; Michael S Donnenberg
Journal:  Mol Microbiol       Date:  2004-06       Impact factor: 3.501

3.  Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1.

Authors:  Takeshi Matsuzawa; Asaomi Kuwae; Sei Yoshida; Chihiro Sasakawa; Akio Abe
Journal:  EMBO J       Date:  2004-08-19       Impact factor: 11.598

4.  Dynamics of [Ca2+] in the endoplasmic reticulum and cytoplasm of intact HeLa cells. A comparative study.

Authors:  M J Barrero; M Montero; J Alvarez
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

5.  SsaM and SpiC interact and regulate secretion of Salmonella pathogenicity island 2 type III secretion system effectors and translocators.

Authors:  Xiu-Jun Yu; Mei Liu; David W Holden
Journal:  Mol Microbiol       Date:  2004-11       Impact factor: 3.501

6.  EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly.

Authors:  Kenneth G Campellone; Douglas Robbins; John M Leong
Journal:  Dev Cell       Date:  2004-08       Impact factor: 12.270

Review 7.  Calcium signalling in bacteria.

Authors:  Delfina C Dominguez
Journal:  Mol Microbiol       Date:  2004-10       Impact factor: 3.501

8.  Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.

Authors:  V K Viswanathan; Athanasia Koutsouris; Sandra Lukic; Mark Pilkinton; Ivana Simonovic; Miljan Simonovic; Gail Hecht
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection.

Authors:  Rosanna Mundy; Liljana Petrovska; Katherine Smollett; Nandi Simpson; Rebecca K Wilson; Jun Yu; Xuanlin Tu; Ilan Rosenshine; Simon Clare; Gordon Dougan; Gad Frankel
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Dissecting virulence: systematic and functional analyses of a pathogenicity island.

Authors:  Wanyin Deng; José L Puente; Samantha Gruenheid; Yuling Li; Bruce A Vallance; Alejandra Vázquez; Jeannette Barba; J Antonio Ibarra; Paul O'Donnell; Pavel Metalnikov; Keith Ashman; Sansan Lee; David Goode; Tony Pawson; B Brett Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

View more
  84 in total

1.  Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.

Authors:  Wanyin Deng; Hong B Yu; Carmen L de Hoog; Nikolay Stoynov; Yuling Li; Leonard J Foster; B Brett Finlay
Journal:  Mol Cell Proteomics       Date:  2012-06-01       Impact factor: 5.911

2.  The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17b.

Authors:  Stephanie R Shames; Matthew A Croxen; Wanyin Deng; B Brett Finlay
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

3.  Impact of the N-terminal secretor domain on YopD translocator function in Yersinia pseudotuberculosis type III secretion.

Authors:  Ayad A A Amer; Monika K Åhlund; Jeanette E Bröms; Åke Forsberg; Matthew S Francis
Journal:  J Bacteriol       Date:  2011-09-30       Impact factor: 3.490

Review 4.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

5.  SepL resembles an aberrant effector in binding to a class 1 type III secretion chaperone and carrying an N-terminal secretion signal.

Authors:  Rasha Younis; Lewis E H Bingle; Sarah Rollauer; Diana Munera; Stephen J Busby; Steven Johnson; Janet E Deane; Susan M Lea; Gad Frankel; Mark J Pallen
Journal:  J Bacteriol       Date:  2010-09-10       Impact factor: 3.490

6.  N-terminal type III secretion signal of enteropathogenic Escherichia coli translocator proteins.

Authors:  Diana Munera; Valerie F Crepin; Olivier Marches; Gad Frankel
Journal:  J Bacteriol       Date:  2010-04-16       Impact factor: 3.490

Review 7.  Type III secretion systems: the bacterial flagellum and the injectisome.

Authors:  Andreas Diepold; Judith P Armitage
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-05       Impact factor: 6.237

8.  Structural analysis of SepL, an enteropathogenic Escherichia coli type III secretion-system gatekeeper protein.

Authors:  Brianne J Burkinshaw; Sergio A Souza; Natalie C J Strynadka
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-09-23       Impact factor: 1.056

9.  Regulation of Type III Secretion of Translocon and Effector Proteins by the EsaB/EsaL/EsaM Complex in Edwardsiella tarda.

Authors:  Lu Yi Liu; Pin Nie; Hong Bing Yu; Hai Xia Xie
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

10.  Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli.

Authors:  Annick Gauthier; Marilyn L Robertson; Michael Lowden; J Antonio Ibarra; José Luis Puente; B Brett Finlay
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.